Discovering Innovations with Improved Pharma at AAPS 2025

Improved Pharma Showcasing Innovations at AAPS 2025

Meet us at Booth #3561 and posters M1030-04-26, M1330-08-54, and T1130-02-10.

Improved Pharma is gearing up for an exciting presence at AAPS 2025. This year, the company occupies a larger corner booth (#3561) adjacent to Varda Space Industries (#3563). The booth is strategically located on the main aisle of the exhibition floor, providing convenient access for attendees. A talented team from Improved Pharma, including Stephen Byrn, Pam Smith, Susan Bogdanowich-Knipp, Ruba Alajlouni, and Lauren Smith will be on hand to engage with visitors. Attendees are encouraged to stop by to discuss their research and development needs, learn more about innovative solid-state chemistry and formulation design, and delve into the intriguing topic of crystallization in microgravity.

Presenting Groundbreaking Research

In line with its commitment to advancing pharmaceutical science, Improved Pharma's latest research has been selected for a Special Poster Collection focusing on Amorphous Solid Dispersions. One of the highlights is a presentation by Dr. Pamela Smith, the Chief Operating Officer, who will discuss "The Use of Raman Mapping and Hot-Stage Microscopy to Detect Micro-Domains of Crystallinity in Amorphous Solid Dispersions of Nilotinib". This presentation is scheduled for a dedicated session featuring five selected posters that were handpicked by recognized expert Bill Williams, III, Ph.D., FAAPS from the University of Texas at Austin.

Details of the Presentation

This special session will take place from 10:30 AM to 11:25 AM at Poster Forum 4. Each participating author will have approximately 10 minutes allocated to present their work and engage with the audience through Q&A. In addition, Dr. Smith's poster will also be featured in the regular poster session on the following day at session T1130-02-10.

Collaborative Research Efforts

Improved Pharma has also partnered with BASF to produce a joint poster titled "Critical Insights into High Drug Load Amorphous Formulations: Challenges and Advanced Techniques". This joint effort will be presented by Dr. Nitin Kumar K. Swarnakar and is set for poster M1330-08-54. This collaborative research showcases the complexities encountered when scaling-up drug formulations, particularly emphasizing the impact of slight variations on dissolution results. The insights gathered from advanced tools, such as Raman mapping, are invaluable, providing essential information regarding the quality across different production batches.

About Improved Pharma

Improved Pharma is a pioneering research and information entity dedicated to optimizing pharmaceutical processes, methods, and formulations. The company offers services that encompass solid-state form studies, formulation design, synchrotron techniques, analytical testing, and expert consulting tailored for the development and protection of intellectual property matters. Established in 2006 by founders Stephen and Sarah Byrn, the firm has a rich history of innovation, having roots linked to SSCI.

Frequently Asked Questions

What is Improved Pharma presenting at AAPS 2025?

Improved Pharma will showcase its latest research on Amorphous Solid Dispersions and several innovative projects at their booth and through poster presentations.

Where can I find Improved Pharma at the event?

You can visit Improved Pharma at Booth #3561 and view their posters at specified locations throughout the exhibition.

Who are the representatives from Improved Pharma at AAPS 2025?

The team will include Stephen Byrn, Pam Smith, Susan Bogdanowich-Knipp, Ruba Alajlouni, and Lauren Smith.

What topics will Dr. Pamela Smith discuss in her presentation?

Dr. Pamela Smith will explore Raman Mapping and Hot-Stage Microscopy as techniques to identify crystallinity in Amorphous Solid Dispersions.

What is the goal of Improved Pharma's research efforts?

Improved Pharma aims to enhance pharmaceutical formulations and processes to ensure improved product quality and efficacy, ultimately contributing to better health outcomes.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.